The Iliac/SFA/Popliteal Center

Filter Your Results

 

News

 

Medtronic's In.Pact Admiral DCB Approved for Reimbursement in France and Belgium

June 9, 2017 -- Medtronic announced the recent reimbursement approvals in France and Belgium for its In.Pact Admiral peripheral drug-coated balloon (DCB) for the treatmen…

ISAR-STATH Compares Interventional Treatments of SFA Disease

June 6, 2017 -- Findings from the ISAR-STATH trial were published by Ilka Ott, MD, et al in Circulation (2017;135:2218 -- 2226). ISAR-STATH is a randomized comparison of pa…

Evaluating the Legflow Device in the LEG-DEB Registry

Eugenio Stabile, MD, PhD

May 2017—A new generation of DCBs could achieve superiority in treating BTK arteries.

VascuFlex® Multi-LOC: Spot Stenting With SeQuent® Please OTW DCB

Klaus Amendt, MD, and Ralf Langhoff, MD

May 2017—Realizing the concept of leave-less-behind after DCB angioplasty in atherosclerotic lesions of the femoropopliteal artery.

PRELUDE Enrollment Completed for Cagent Vascular's Serranator Alto PTA Device

June 5, 2017 -- Cagent Vascular announced the completion of enrollment in the first-in-human PRELUDE study of the company's Serranator Alto percutaneous transluminal angio…

First-in-Human Study of Med Alliance's Selution DCB Completes Enrollment

May 30, 2017 -- Med Alliance Group, Inc., a Switzerland-based company, announced completion of patient enrollment in the first-in-human (FIH) evaluation of the Selution siroli…

FDA Approves Phase 1 Trial of Alucent Medical's Natural Vascular Scaffold Therapy

May 16, 2017 -- Alucent Medical, Inc. announced that it has received US Food and Drug Administration (FDA) approval to begin phase 1 human clinical studies of the company'…

QT Vascular and Medtronic Enter Into Asset Purchase Option Agreement for the Chocolate PTA Catheter

May 12, 2017 -- QT Vascular Ltd. announced that it has entered into an asset purchase option agreement with Medtronic for the acquisition of QT Vascular's non -- drug-coat…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.